|
Cập nhật một số ấn phẩm nghiên cứu liên quan đến miễn dịch và điều trị bệnh ghẻ do Sarcopter scabies
Ghẻ là một bệnh truyền nhiễm có thể gây thành dịch do động vật chân đốt Sarcoptes scabies gây ra ở người và một số động vật, phần lớn chúng gây bệnh ở các quốc gia nhiệt dới nóng ẩm và trong đó có cả Việt Nam. Đặc biệt bệnh có thể lây lan rất nhanh trong môi trường sống đông đúc, sử dụng chung quần áo, mềm chiếu, và khăn mặt như các nhà trẻ, trại quân đội, nhà tù và khu nội trú,…Bệnh dễ phát hiện và điều trị khỏi lệ thuộc vào khâu vệ sinh và chăm sóc thuốc. Gần đây, các nhà khoa học đã nghiên cứu sâu về vấn đề miễn dịch, chẩn đoán phân tử và đặc biệt điều chế vaccine để chống lại căn bệnh này. Dưới đây là một số công trình nghiên cứu như thế nhằm chia sẻ thông tin với các đồng nghiệp trong thực hành lâm sàng dễ nhầm lẫn với các thương tổn trên da khác như nốt muỗi đốt, mụn trứng cá, viêm da cơ địa bội nhiễm, chàm,…
1.Abd El-Aal AA, Hassan MA, Gawdat HI, Ali MA, Barakat M. (2016). Immunomodulatory impression of anti and pro-inflammatory cytokines in relation to humoral immunity in human scabies.Int J Immunopathol Pharmacol. 2016 Jan 26. pii: 0394632015627464 2.Ahmad HM, Abdel-Azim ES, Abdel-Aziz RT. (2016). Clinical efficacy and safety of topical versus oral ivermectin in treatment of uncomplicated scabies. Dermatol Ther. 2016 Jan;29(1):58-63. 3.Alipour H, Goldust M. et al., (2015). The efficacy of oral ivermectin vs. sulfur 10% ointment for the treatment of scabies. Ann Parasitol. 2015;61(2):79-84 4.Andriantsoanirina V, Ariey F, Izri A, Bernigaud C, Fang F et al., (2015). Sarcoptes scabiei mites in humans are distributed into three genetically distinct clades. Clin Microbiol Infect. 2015 21(12)-1107-14. 5.Arlian LG, Feldmeier H, Morgan MS. (2015). The potential for a blood test for scabies. PLoS Negl Trop Dis. 2015 Oct 22;9(10):e0004188. 6.Alessandro Balestrieri, Luigi Remonti, Nicola Ferrariet al., (2006). Sarcoptic mange in wild carnivores and its co-occurrence with parasitic helminths in the Western Italian Alps.European Journal of Wildlife Research 52:3, 196-201. 7.Arián Ráez-Bravo, José Enrique Granados, José Joaquín Cerón et al., (2015). Acute phase proteins increase with sarcoptic mange status and severity in Iberian ibex (Capra pyrenaica, Schinz 1838). Parasitology Research 114:11, 4005-4010. 8.Arián Ráez-Bravo, José Enrique Granados, Emmanuel Serrano et al., (2016). Evaluation of three enzyme-linked immunosorbent assays for sarcoptic mange diagnosis and assessment in the Iberian ibex, Capra pyrenaica. Parasites and Vectors 9:1. 9.Arnaud A, Chosidow O, Detrez MA, Bitar D, Huber F et al., (2015). Prevalences of scabies and pediculosis corporis among homeless in the Paris region: results from 2 random cross-sectional surveys (HYTPEAC study). Br J Dermatol. 2015 Oct 16. doi: 10.1111/bjd.14226. 10.Banzhaf CA, Themstrup L, Ring HC, Welzel J, Mogensen M, Jemec GB. (2013). In vivo Imaging of Sarcoptes scabiei infestation using optical coherence tomography. Case Rep Dermatol. 2013 Jun 1;5(2):156-62. 11.Bécourt C, Marguet C, Balguerie X, Joly P. (2013). Treatment of scabies with oral ivermectin in 15 infants: a retrospective study on tolerance and efficacy. Br J Dermatol. 2013 May 31. 12.Boralevi F, Diallo A, Miquel J, Guerin-Moreau M, Bessis D et al., (2014). Clinical phenotype of scabies by age.Pediatrics. 2014 Apr;133(4):e910-6. 13.Brian S. Fuchs, Allen N. Sapadin, Robert G. Phelps et al., (2007). Diagnostic dilemma: Crusted scabies superimposed on psoriatic erythroderma in a patient with acquired immunodeficiency syndrome. SKINmed 6:3, 142-144. 14.Carapetis JR, Conors C, Yarmirr D, Krause V, Currie BJ (1997). Success of a scabies control program in an Australian aboriginal community.Pediatr. Infect. Dis. J. 1997 May; 16(5): 494-9. 15.Charles V.Sanders, Lee T . Nesbittet al., (1997). Scabies.Medical Progress, Vol 24, No 12: 35-39. 16.Chung SD, Wang KH, Huang CC, Lin HC. (2013). Scabies increased the risk of chronickidney disease: a 5-year follow-up study.J Eur Acad Dermatol Venereol. 2013 Feb 1. 17.Cinotti E, Perrot JL, Labeille B, Cambazard F. (2015). Reflectance confocal microscopy for cutaneous infections and infestations. J Eur Acad Dermatol Venereol. 2015 Sep 21. 18.Claudia Salvadori, Guido Rocchigiani, Camilla Lazzarottiet al., (2016). Histological lesions and cellular response in the skin of Alpine chamois (Rupicapra r. rupicapra) spontaneously affected by Sarcoptic mange. BioMed Research International,1-8. 19.Clair Fuller et al., (2013). Epidemiology of scabies. Current Opinion in Infectious Diseases 26(2):123-6 20.Currie B, McCarthy Jet al., (2010). Permethrin and ivermectin for scabies. N Engl J Med 2010; 362:717–725. 21.Castillo AL, Osi MO, Ramos JD, De Francia JL, Dujunco MU, Quilala PF. (2013). Efficacy and safety of Tinospora cordifolia lotion in Sarcoptes scabiei var hominis-infected pediatric patients: A single blind, randomized controlled trial. J Pharmacol Pharmacother. 2013 Jan;4(1):39-46. 22.Cote NM, Jaworski DC, Wasala NB, Morgan MS, Arlian LG (2013). Identification and expression of macrophage migration inhibitory factor in Sarcoptes scabiei. Exp Parasitol. 2013 Jul 4;135(1):175-181. 23.Currie BJ. Et al., (2015). Scabies and Global Control of Neglected Tropical Diseases.
N Engl J Med. 2015 Dec 10;373(24):2371-2. 24.David Young et al., (1990). Scabies.Andew’ Diseases of the skin; 523-527. 25.Davis JS, McGloughlin S, Tong SY, Walton SF, Currie BJ. (2013). A novel clinical grading scale to guide the management of crusted scabies. PLoS Negl Trop Dis. 2013 Sep 12;7(9):e2387. 26.S. Dean Rider, Marjorie S. Morgan, Larry G. Arlian. (2015). Draft genome of the scabies mite. Parasites & Vectors 8:1. 27.Edison L, Beaudoin A, Goh L, Introcaso CE, Martin D et al., (2015). Scabies and Bacterial Superinfection among American Samoan Children, 2011-2012. PLoS one. 2015 Oct 12;10(10):e013933. 28.Engelman D, Kiang K, Chosidow O, McCarthy J et al., (2013). Toward the global control of human scabies: introducing the international alliance for the control of scabies.PLoS Negl Trop Dis. 2013 Aug;7(8):e2167. 29.Engelman D, Martin DL, Hay RJ, Chosidow O, McCarthy JS, Fuller LC, Steer AC. (2013). Opportunities to investigate the effects of ivermectin mass drug administration on scabies. Parasit Vectors. 2013 Apr 17;6:106. 30.Fischer K, Holt D, Currie B, Kemp D. (2012). Scabies: important clinical consequences explained by new molecular studies. Adv Parasitol. 2012;79:339-73. 31.FitzGerald D, Grainger RJ, Reid A. (2014). Interventions for preventing the spread of infestation in close contacts of people with scabies. Cochrane Database Syst Rev. 2014 Feb 24;2:CD009943. 32.Fujimoto K, Kawasaki Y, Morimoto K, Kikuchi I, Kawana S. (2014). Treatment forcrusted scabies: limitations and side effects of treatment with ivermectin. J Nippon Med Sch. 2014;81(3):157-63. 33.Goksugur SB, Karatas Z, Goksugur N, Bekdas M et al., (2015). Metabolic acidosis in an infant associated with permethrin toxicity. Pediatr Dermatol. 2015;32(1):e15-7. 34.Haar K, Romani L, Filimone R, Kishore K, Tuicakau M, Koroivueta J, Kaldor JM, Wand H, Steer A, Whitfeld M. (2014). Scabies community prevalence and mass drug administration in two Fijian villages. Int J Dermatol. 2014 Jun;53(6):739-45. 35.Hay RJ, Johns NE, Williams HC, Bolliger IW, Dellavalle RP et al., (2014). The global burden of skin disease in 2010: an analysis of the prevalence and impact of skin conditions.J Invest Dermatol. 2014 Jun;134(6):1527-34. 36.Hay RJ, Steer AC, Chosidow O, Currie BJ. (2013). Scabies: A suitable case for a global control initiative. Curr Opin Infect Dis. 2013 Apr;26(2):107-9. 37.Hegazy AA, Darwish NM, Abdel Hamid IA, Hammad SM (1990). Epidemiology and control of scabies in an Egyptian village.Int. J. Dermatol; 38 (9): 291-5. 38.Heukelbach J, Mazigo HD, Ugbomoiko US. (2013). Impact of scabies in resource-poor communities. Curr Opin Infect Dis. 2013 Apr;26(2):127-32. 39.Hewitt KA, Nalabanda A, Cassell JA. (2015). Scabies outbreaks in residential care homes: factors associated with late recognition, burden and impact. A mixed methods study in England. Epidemiol Infect. 2015 May;143(7):1542-51. 40.Holt DC, Fischer K. et al., (2013). Novel insights into an old disease: Recent developments in scabies mite biology. Curr Opin Infect Dis. 2013 Apr;26(2):110-5. 41.H. Hunter Handsfield et al., (1992). Scabies. Colour Atlas and synopsis ofsexually transmitted diseases. 1992. 42.I to T. et al., (2013). Mazzotti reaction with eosinophilia after undergoing oral ivermectin for scabies. J Dermatol. 2013 Sep;40(9):776-7. 43.Jacks SK, Lewis EA, Witman PM. (2012). The curette prep: a modification of the traditional scabies preparation. Pediatr Dermatol. 2012 Jul-Aug;29(4):544-5. 44.Jörg Heukelbach, Hermann Feldmeieret al.,(2006). Scabies. The Lancet 367:9524, 1767-1774. 45.Karthikeyan, K et al., (2007). Scabies in children. Arch Dis Child Educ Pract;92:65-69 46.Kate E. Mounsey, James S. McCarthy, Shelley F. Walton. (2013) Scratching the itch: new tools to advance understanding of scabies. Trends in Parasitology 29:1, 35-42. 47.Katja Fischer, Deborah Holt, Bart Currie, David Kemp (2012). Scabies. Advances in Parasitology, 339-373. 48.Kearns T, Clucas D, Connors C, Currie BJ, Carapetis JR, Andrews RM. (2013). Clinic attendances during the first 12 months of life for Aboriginal children in five remote communities of northern Australia. PLoS one. 2013;8(3):e58231. 49.Kearns TM, Speare R, Cheng AC, McCarthy J, Carapetis JR, Holt DC, Currie BJ, Page W, Shield J, Gundjirryirr R, Bundhala L, Mulholland E, Chatfield M, Andrews RM (2015). Impact of an ivermectin mass drug administration on Scabies prevalence in a remote Australian aboriginal community. PLoS Negl Trop Dis. 2015 Oct 30;9(10):e0004151. 50.KenawiMZ, Morsy TA, Abdalla KF, Hady HM (1993). Treatment of human scabies by sulfur and permethrine.J. Egypt. Soc. Parasitol.; 23 (3): 691-6. 51.Kouotou EA, Nansseu JR, Sieleunou I, Defo D, Bissek AC, Ndam EC. (2015). Features of human scabies in resource-limited settings: the Camerooncase. BMC Dermatol. 2015 Jul 23;15:12. 52.Landwehr D, Keita SM, Ponnighaus JM, Tuonkara C (1998). Epidemiologic aspects of Scabies in Mali, Malawi and Cambodia.Int. J Dermatol.; 37 (8):588-590. 53.Larry G. Arlian, Ndate Fall, Marjorie S. Morgan. (2007). In vivoevidence that Sarcoptes scabiei (Acari: Sarcoptidae) is the source of molecules that modulate splenic gene expression. Journal of Medical Entomology 44:6, 1054-1063. 54.Larry G. Arlian, Marjorie S. Morgan, S. Dean Rider(2016). Sarcoptes scabiei:Genomics to proteomics to biology. Parasites and Vectors 9:1. 55.X. Liu, S. F. Walton, H. C. Murray, M. Kinget al., (2014). Crusted scabies is associated with increased IL-17 secretion by skin T cells. Parasite Immunology 36:11, 594-604. 56.Liu X, Walton S, Mounsey K. et al., (2014). Vaccine against scabies: necessity and possibility. Parasitology. 2014 May;141(6):725-32. 57.Lokuge B, Kopczynski A, Woltmann A, Alvoen F et al., (2014). Crusted scabies in remote Australia, a new way forward: lessons and outcomes from the East arnhem scabies Control program. Med J Aust. 2014 Jun 16;200(11):644-8. 58.Luo B, Liao F, Hu Y, Liu XI, He Y, Wu L, Tan H, Luo L, Zhou Y, Mo Q, Deng J, Wei Y. (2015). Acaricidal activity of extracts from Ligularia virgaurea against the Sarcoptes scabiei mite in vitro. Exp Ther Med. 2015 Jul;10(1):247-250. 59.Manjhi PK, Sinha RI, Kumar M, Sinha KI. (2014). Comparative study of efficacy of oral ivermectin versus some topical antiscabies drugs in the treatment of scabies.
J Clin Diagn Res. 2014 Sep;8(9):01-4. 60.Marjorie S. Morgan, Larry G. Arlian, S. Dean Rideret al., (2016). A proteomic analysis of Sarcoptes scabiei (Acari:Sarcoptidae). Journal of Medical Entomology 53:3, 553-561. 61.Marcia RamosE Silva, Giovan Cosimo Bonomo (1998). Discover of the etiology of Scabies. Int J Dermatol.; 37 (8): 625-630. 62.Marks M, Taotao-Wini B, Satorara L, Engelman D, Nasi T, Mabey DC, Steer AC. (2015).Long term control of Scabies fifteen years after an intensive treatment programme. PLoS Negl Trop Dis. 2015 Dec 1;9(12):e0004246. 63.Mathieu Sarasa, Luisa Rambozzi, Luca Rossi et al., (2010). Sarcoptes scabiei: Specific immune response to sarcoptic mange in the Iberian ibex Capra pyrenaica depends on previous exposure and sex. Experimental Parasitology 124:3, 265-271. 64.McLean FE. (2013). The elimination of scabies: a task for our generation.
Int J Dermatol. 2013 Oct;52(10):1215-23. 65.Meinking TL, Taplin D, Hermida JL, Pardo R, Kerdel FA (1995). The treatment of scabies with invermectin.N Engl J Med. 6; 333 (1): 26-30. 66.Micali G, Lacarrubba F, Verzì AE, Nasca MR. (2015). Low-cost equipment for diagnosis and management of endemic scabies outbreaks in underserved populations. Clin Infect Dis. 2015 Jan 15;60(2):327-9. 67.Mika A, Reynolds SL, Pickering D, McMillan D, Sriprakash KS et al., (2016). Complement inhibitors from scabies mites promote streptococcal growth--a novel mechanism in infected epidermis? PLoS Negl Trop Dis. 2012;6(7):e1563. 68.Mika A, Reynolds SL, Mohlin FC, Willis C, Swe PM et al., (2012). Novel scabies mite serpins inhibit the three pathways of the human complement system. PLoS one. 2012;7(7):e40489.. 69.Miyajima A, Hirota T, Sugioka A, Fukuzawa M, Sekine M et al., (2016). Effect of high fat meal intake on the pharmacokinetics profile of ivermectin in Japanese patients. J Dermatol. 2016 Feb 26. 70.Mofiz E, Seemann T, Bahlo M, Holt D, Currie BJ, Fischer K, Papenfuss AT (2016). Mitochondrial genomesequence of the Scabies mite provides insight into the genetic diversity of individual Scabies infections. PLoS Negl Trop Dis. 2016 Feb 12;10(2):e0004384. 71.Mounsey KE, McCarthy JS. (2013). Treatment and control of scabies.Curr Opin Infect Dis. 2013 Apr;26(2):133-9. 72.Mounsey KE, McCarthy JS, Walton SF. (2013). Scratching the itch: new tools to advance understanding of scabies. Trends Parasitol. 2013 Jan;29(1):35-42. 73.Mounsey KE, Bernigaud C, Chosidow O et al.,(2016). Prospects for Moxidectin as a new oral treatment for human scabies. PLoS Negl Trop Dis. 2016 Mar 17;10(3):e0004389. 74.National Society of Histotechnology (2015). Guidelines for the management of scabies. 75.Panuganti B, Tarbox M. (2013). Evaluation and management of pruritus and scabies in the elderly population. Clin Geriatr Med. 2013 May;29(2):479-99. 76.Park JH, Kim CW, Kim SS. (2012). The diagnostic accuracy of dermoscopy for scabies. Ann Dermatol. 2012 May;24(2):194-9. 77.Pasay C, Mounsey K, Stevenson G, et al., (2010). Acaricidal activity of eugenol based compounds against scabies mites. PLoS one 2010; 5:e12079. 78.D.B. Pence & E. Ueckermann et al.,(2002). Sarcoptic mange in wildlife. Scientific and Technical Review of the World Organisation for Animal Health 21(2): 385-398. 79.Reynolds SL, Pike RN, Mika A, Blom AM, Hofmann Aet al., (2014). Scabies mite inactive serine proteases are potent inhibitors of the human complement lectin pathway. PLoS Negl Trop Dis. 2014 May 22;8(5):e2872. 80.Rider SD Jr, Morgan MS, Arlian LG. et al., (2015). Draft genome of the scabies mite. Parasit Vectors. 2015 Nov 10;8:585. 81.Rieko Kabashima, Kenji Kabashima, Ryosuke Hino et al., (2008). Scabies superimposed on skin lesions of adult T-cell leukemia/lymphoma: Case report and literature review. International Journal of Dermatology 47:11, 1168-1171. 82.Romani L, Steer AC, Whitfeld MJ, Kaldor JM. (2015). Prevalence of scabies and impetigo worldwide: a systematic review. Lancet Infect Dis. 2015 Aug;15(8):960-7. 83.Romani L, Koroivueta J, Steer AC, Kama M, Kaldor JM et al., (2015).
Scabies and impetigo prevalence and risk factors in Fiji: A national survey.
PLoS Negl Trop Dis. 2015 Mar 4;9(3):e0003452. 84.Romani L, Whitfeld MJ, Koroivueta J, Kama M, Wand H et al., (2015). Mass drug administration for scabies control in a population with endemic disease. N Engl J Med. 2015 Dec 10;373(24):2305-13. 85.Sagua H, RiveraAM, ZamoraM,NeiraI, ArayaJ (1997). Epidemioligical stydy of pediculosis capitis and scabies in schoolchildren from Antofagasta, Chile, 1995.Bol. Chil. Parasitol; 52 (1-2): 33-6. 86.SharbaughRJet al., (1997). Scabies: An itchy problem-Home care providing; 2(3): 115 87.Sharma R, Singal A et al., (2011). Topical permethrin and oral ivermectin in the management of scabies: A prospective, randomized, double blind, controlled study. Indian J Dermatol Venereol Leprol 2011; 77:581-6. 88.Sharma G, Dhankar G, Thakur K, Raza K, Katare OP. (2015). Benzyl benzoate-loaded microemulsion for topical applications: Enhanced dermatokinetic profile and better delivery promises. AAPS PharmSciTech. 2015 Dec 15. 89.Shelley F. Walton and Florin I. Oprescuet al.,(2013) Immunology of scabies and translational outcomes. Current Opinion in Infectious Diseases 26:2, 116-122. 90.Shimose L, Munoz-Price LS. et al., (2013). Diagnosis, prevention and treatment of scabies. Curr Infect Dis Rep. 2013 Oct;15(5):426-31. 91.Strong M, Johnstone PWet al., (2010). Interventions for treating scabies update. Cochrane Database Syst Rev 2010:CD000320. 92.Swe PM, Reynolds SL, Fischer K.et al., (2014). Parasitic scabies mites and associated bacteria joining forces against host complement defence. Parasite Immunol. 2014 Nov;36(11):585-93. 93.Swe PM, Zakrzewski M, Kelly A, Krause L, Fischer K. (2014). Scabies mites alter the skin microbiome and promote growth of opportunistic pathogens in a porcine model. PLoS Negl Trop Dis. 2014 May 29;8(5):e2897. 94.Tasani M, Tong SY, Andrews RM, Holt DC, Currie BJet al.,(2015).The importance of scabies co-infection in the treatment considerations for impetigo.Pediatr Infect Dis J. 2015 Nov 23. 95.Timothy G.Berger, Peter M.Elias, Bruce. Het al., (1990). Scabies.Manual of therapy for skin diseases. USA. 1990.268-270. 96.Thomas J, Carson CF, Peterson GM, Walton SF et al., (2016). Therapeutic potential of tea tree oil for scabies. Am J Trop Med Hyg.3;94(2):258-66. 97.Veraldi S, Nazzaro G, Serini SM. (2015).Treatment of crusted scabies with acitretin. Br J Dermatol. 2015 Sep;173(3):862-3. 98.Walton SF, Oprescu FI. (2013). Immunology of scabies and translational outcomes: identifying the missing links. Curr Opin Infect Dis. 2013 Apr;26(2):116-22. 99.William L. Weston, Alffred T.Lane, Joseph G.Morelli (1996). Scabies. Colour textbook of Pediatrics Dermotology; 84-87. 100.WHO (1997). Repellent chemical method for the control of arthropod vector and pest of public health importance. WHO pesticide evaluation Schema; 70-73. 101.WHO (1997). Scabies mite. Vector Control, 1997.279-282. 102.WHO (2005). Epidemiology and management of common skin diseases in children in developing countries. WHO/FCH/CAH/05.12 103.Worth C, Heukelbach J, Fengler G, Walter Bet al.,(2012). Impaired quality of life in adults and children with scabies from an impoverished community in Brazil. Int J Dermatol. 2012 Mar;51(3):275-82. 104.Wong SS, Poon RW, Chau S, Wong SC, To KKet al.,(2015).Development of conventional and real-time quantitative PCR assays for diagnosis andmonitoring of scabies. J Clin Microbiol. 2015 Jul;53(7):2095-102. 105.Xiaobin Gu, Yue Xie, Shuxian Wang et al., (2014). Immune response induced by candidate Sarcoptes scabiei var. cuniculi DNA vaccine encoding paramyosin in mice. Experimental and Applied Acarology 63:3, 401-412. 106.Zhang R, Jise Q, Zheng W, Ren Y, Nong X et al.,(2012). Characterization and evaluation of a Sarcoptes scabiei allergen as a candidate vaccine. Parasit and Vectors. 2012 Aug 16;5:176. 107.Zheng Y, He R, He M, Gu X, Wang T, Lai Wet al.,(2016). Characterization of Sarcoptes scabiei cofilin gene and assessment of recombinant cofilin protein as an antigen in indirect-ELISA for diagnosis. BMC Infect Dis. 2016 Jan 22;16(1):21. Một số tài liệu tiếng Việt có thể tham khảo 108.Abram S. Beneson và Lê Kinh Duệ (1997). Bệnh ghẻ, Sổ tay kiểm soát các bệnh truyền nhiễm.Nhà xuất bản Y học 1997, trang 118-121. 109.Trần Lan Anh (1996). Đặc điểm bệnh ngoài da tại mộtsố xã huyện Thanh Trì Hà Nội ảnh hưởng của môi trường sống đến mô hình bệnh tật. Nội san Da liễu, Số 2, trang 15-24. 110.Bộ môn Da liễu (1994). Bệnh ghẻ. Bài giảng Da liễu, Nhà xuất bản Y học, trang 25-27. 111.Lê Kinh Duệ (1979). Bệnh ghẻ. Điều trị học bệnh da và hoa liễu. Nhà xuất bản Y học, trang 142-146. 112.Nguyễn Thị Đào, Nguyễn Văn Điển, Nguyễn Khắc Hiếu và cs., (1977). Tình hình bệnh ngoài da và hoa liễu ở một trại phạm nhân nữ Lào Cai. Da liễu, Số 1, trang 5-11. 113.Nguyễn Thị Hồng Hạnh, Nguyễn Thanh Tùng, Ngô Văn Lực (1997). Tình hình bệnh da ở trẻ em tại Phòng khám Bệnh viện Da liễu Đà Nẵng trong 2 năm 1995-1996. Nội san Da liễu, Số 3, trang 33-36. 114.Nguyễn Xuân Hiển, Mạnh Khương, Nguyễn Thị Công (1969). Kết quả điều trị ghẻ hàng loạt ở vườn trẻ X. Da liễu, 1969, Số 1, trang 40-43. 115.Nguyễn Xuân Hiền, Trương Mộc Lợi, Bùi Khánh Duy (1991). Ghẻ. Bệnh ngoài da và hoa liễu, 1991, Tập 1, Trang 96-101. 116.Nguyễn Xuân Hiền và cs., (1964). Kết quả điều trị ghẻ hàng loạt ở một đơn vị bộ đội. Nôi san Da liễu, 1964, Số 4, Trang 47-53. 117.Nguyễn Thái Hồng, Nguyễn Cảnh Cầu (1991). Một số nhận xét vế cơ cấu bệnh Da liễu ở một đơn vị bộ binh tuyến biên giới phia Bắc. Công trình NCKH chọn lọc của Ngành Da liễu Việt Nam, Bộ Y tế, Viện Da liễu Việt Nam, 01/1991, trang 67. 118.Hoàng Văn Minh (1997). Ghẻ. Bệnh Da liễu, 1997,trang 197-208. 119.Hoàng Văn Minh (1992). Ghẻ. Bệnh da và các bệnh lây qua đường tình dục, Sở Y tế Thành phố Hồ Chí Minh, 1992, trang 318-321. 120.Phan Phương, Võ Khắc Ngữ, Trần Trung Mẫn, Tống Xuân Nghĩa (1991). Cơ cấu bệnh Da liễu ở Phòng khám Bệnh viện Quân y 103 (1987-1988). Công trình NCKH chọn lọc của Ngành Da liễu Việt Nam, Bộ Y tế-Viện Da liễu Việt Nam, Hà Nội, trang 79. 121.Lương Trường Sơn (2015). Bệnh ghẻ. http://www.impehcm.org.vn 122.Diệp Xuân Thanh, Nguyễn Duy Hưng (1996). Kết quả điều trị bệnh nhân ghẻ bằng xà phòng Tetmosol. Nội san Da liễu, 1996, Số 4, trang 24-26. 123.Huỳnh Văn Trượng và cs., (1989). Báo cáo tổng kết nghiên cứu tác dụng của cặn dầu tràm điều trị bệnh ghẻ tại BV Da liễu TP. Hồ Chí Minh. Nội san Da liễu, trang 51-55. 124.Huỳnh Văn Trượng và cs., (1990). Báo cáo tổng kết nghiên cứu tác dụng hỗn hợp dầu sả 30% Điều trị bệnh ghẻ tại BV Da liễu TP. Hồ Chí Minh. Nội san Da liễu, trang 75-80. 125.Lê Tử Vân (1994). Ghẻ. Bách khoa thư bệnh học, 1994, tập 2, trang 250-252.
|
TRANG CHỦ
